177Lu-TLX250
177Lu-TLX250-302
Phase 3 other active
Quick answer
177Lu-TLX250 for ccRCC is a Phase 3 program (other) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- ccRCC
- Phase
- Phase 3
- Modality
- other
- Status
- active